ADXS-HPV regulatory update

FDA granted Orphan Drug designation for ADXS-HPV from Advaxis to treat HPV-associated head and neck cancer. The live Listeria monocytogenes-based immunotherapy expressing HPV type 16 E7 is in Phase I ...